Significant Financial Burden Associated With Thyroid Cancer Treatment, Survivorship
An analysis of studies in the literature sought to determine the financial burden patients with thyroid cancer incur from diagnosis, treatment, and surveillance.
An analysis of studies in the literature sought to determine the financial burden patients with thyroid cancer incur from diagnosis, treatment, and surveillance.
The use of proton beam therapy (PBT) increased between 2004 and 2018, particularly for cancers in which the effectiveness of PBT is still under investigation.
A high neutrophil-lymphocyte ratio appears to be an independent predictor of outcomes for some patients with head and neck cancer.
The risk score can improve upon EBV-based screening, according to researchers.
Progression-free survival prolonged with tislelizumab + chemotherapy versus chemotherapy alone in recurrent/metastatic NPC.
Pembrolizumab plus chemotherapy did not improve overall survival in patients with a PD-L1 combined positive score below 1.
Induction with paclitaxel, cisplatin, and capecitabine proved more effective than cisplatin plus fluorouracil.
A pilot study sought to determine if the use of a wearable device could improve adverse effect recognition and management in patients with head and neck cancer.
Findings from a case series demonstrated the effect of manual therapy on interincisal opening in patients with head and neck cancers.
Study reveals a key indicator for the need to assess head and neck cancer survivors for risk of anxiety and depression.